LATS2 and Miyoshi myopathy: These results confirmed that the synthetic lethality induced by LATS2-SMG6/TERT observed in vitro also occurs in vivo, suggesting the possibility that TERT and SMG6 are effective against LATS2-mutated cancers such as MM.